TheFiscalFinder
Contractors / Glaxosmithkline, LLC

Glaxosmithkline, LLC

prime recipient of federal awards · UEI FRHTPHMZMX47 ✓ from source
$1.2B
obligated · FY2024
6
funding agencies
100%
from Health and Hum…
6
states
5%
in North Carolina
8
industries

Obligations by year

≈ computed
$850.1M
FY23
$1.2B
FY24
$980.5M
FY25
15%
since FY23

Where this money comes from

✓ from source
FUNDING AGENCIES
GLAXOSMITHKLINE, LLC
HHS
$1.2B
5 other agencies
$0B
Glaxosmithkline, LLC
$1.2B
FY2024 obligated
band width = obligations · FY2024 · source: USASpending.gov

Biggest awards (total value)

awarded 2017$682.2M

Total value over each award’s life, for awards active in FY2024: a decades-long contract can exceed one year’s obligations above.

Where the work lands

North Carolina✓ from source$59.3M
Oklahoma✓ from source$2.8M
Virginia✓ from source$439.2K
California✓ from source$402.6K
Minnesota✓ from source$60.6K

Competitors

Mckesson Corporation≈ computed$11.9B
Pfizer Inc≈ computed$700.6M
Alvogen, Inc.≈ computed$227.7M
Bavarian Nordic A/S≈ computed$143.6M
Trillamed LLC≈ computed$1.5M

computed from shared NAICS, not a stated rivalry.

Corporate family

Single registration: no combined family.

Political contributions

Glaxosmithkline LLC PAC (Gsk PAC)gave$144Kto members of Congress, 2024 cycle✓ from source

linked through public filings, not a claim of coordination. contribution reported to the FEC, a public campaign-finance record.

🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.